Inhibikase Therapeutics Reports First Quarter Financial Results and Highlights Recent Period Activity
/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase...
Source: prnewswire.com